Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:45 PM
Ignite Modification Date:
2025-12-24 @ 3:45 PM
NCT ID:
NCT00160992
Eligibility Criteria:
Inclusion Criteria:
* Stage IV melanoma
* tumor expressing Melan-A
* patient of HLA-A2 subtype
* Detectable immune response after peptide vaccination with Melan-A
* Disease progression during peptide vaccination
Exclusion Criteria:
* Cerebral metastases
* rapidly progressive disease, that necessitates systemic chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00160992
Study Brief:
Protocol Section:
NCT00160992